The Biomarkers Consortium

The Biomarkers Consortium is a collaborative effort among government agencies, industry, and researchers aimed at developing and validating biological indicators—called biomarkers—that can improve disease detection, diagnosis, and treatment. These biomarkers can include things like blood tests or imaging results that provide measurable signs of health or disease. By working together, the consortium speeds up the process of discovering and applying these markers, ultimately helping to make healthcare more personalized and effective. It covers a wide range of conditions, from heart disease to Alzheimer’s, fostering innovation and improving patient outcomes.